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The bottom line is that a variant of the N channel’s
Splicing It Up: A Variant exon 37 is expressed primarily on a subset of small
nociceptive neurons. Exon37a replaces 37b, the usualof the N-Type Calcium Channel
variant, in a fraction of the N channels in some nocicep-Specific for Pain
tors, but this is less likely to happen in nonnociceptors.
Specifically, 55% of neurons that respond to capsaicin
express exon 37a, whereas only 20% of capsaicin-insen-
sitive neurons do so. Cells expressing exon 37a areHow would you make a drug that inhibits pain without
likely also to express NaV1.8. Expression of exon 37a isside effects? The most obvious strategy for analgesia
undetectable in tissue other than sensory neurons.targets molecules that are expressed only on neurons
What is the functional significance of exon 37a? Theused for pain. In this issue of Neuron, Bell et al. report
capsaicin-sensitive cells that express it have about 60%a new splice variant of a calcium channel that controls
greater N channel current densities than those without
neurotransmitter release and show that it is expressed
it. When expressed in oocytes, calcium channels with
primarily on nociceptors, the sensory neurons that
the e37a variant are opened by somewhat smaller (10
trigger pain. mV) voltage stimuli than the e37b variant. We should
suspect that further study will unveil additional function.
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channel (more properly known as CaV2.2; Ertel et al., which differ between the variants) of the C-terminal,
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and in humans (Scott et al., 2002). Mice that lack the N channels to neuronal protein binding partners such as
channel gene respond less to noxious stimuli than do the ORL1 (nociceptin) receptor (Beedle et al., 2004).
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Neuron
4
Lipscombe, D., Pan, J.Q., and Gray, A.C. (2002). Mol. Neurobiol.iting. If the e37 region contributes to an interface that
26, 21–44.binds the N channel to other proteins, there is reason
Meir, A., Ginsburg, S., Butkevich, A., Kachalsky, S.G., Kaiserman,to be optimistic about both these questions.
I., Ahdut, R., Demirgoren, S., and Rahamimoff, R. (1999). Physiol.Targeting a nociceptor-specific calcium channel is not
Rev. 79, 1019–1088.
the only strategy for making a calcium antagonist that
Penn, R.D., and Paice, J.A. (2000). Pain 85, 291–296.is analgesic. The other is to block N channels only when
Saegusa, H., Kurihara, T., Zong, S., Kazuno, A., Matsuda, Y., Nonaka,they are hyperactive. This should selectively relieve in-
T., Han, W., Toriyama, H., and Tanabe, T. (2001). EMBO J. 20, 2349–
tense, persistent pain because it is then that calcium 2356.
channels are most active on nociceptors. The devil is
Scott, D.A., Wright, C.E., and Angus, J.A. (2002). Eur. J. Pharmacol.
in the kinetic details of the channel and of the putative 451, 279–286.
drug, but the concept of state-dependent block is cen- Triggle, D.J. (1999). Eur. J. Pharmacol. 375, 311–325.
tral to drug design against ion channels, in general, and
is the basis of the most widely used calcium channel
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for a weak heart to perfuse them. The problem is that
cardiac and smooth muscle calcium channels are virtu-
ally identical and the heart stops if its calcium channels
Studies in invertebrates and vertebrates have demon-are blocked. Preferential block occurs only because
strated a critical role for cAMP signaling and adenylylsmooth muscle has a lower rest potential than cardiac
cyclase (AC) activity in learning and memory. In thismuscle, and this puts its calcium channels into a gating
issue of Neuron, Pineda et al. show that in the hippo-state to which dihydropyridines bind with particular
campus, reduction of AC activity via the inhibitory Gstrength. Thus, state-dependent binding turns this par-
protein Gi is critical for memory formation, suggestingticular drug from lethal to useful.
that a balance of inhibitory and stimulatory regulatorsThere is a holy grail of analgesic drug design. It is not
of AC is required for optimal cAMP signaling.just to inhibit pain without side effects; it is to inhibit
pathological pain without side effects. Acute pain is
useful because it tells us of danger. But pain becomes Neuronal signaling is regulated by multiple pathways
counterproductive when it is excessive, lasts long after that convey signals through cells independently and/or
an injury, or becomes completely dissociated from sen- via cross-talk with neighboring pathways. The cAMP-
sory input. The success of calcium channel blockers in dependent pathway is a ubiquitous communication de-
the cardiovascular field, the possibility of making state- vice within neurons that is extremely efficient, versatile,
dependent blockers against neuronal calcium channels, and multimodal, and is able to integrate two major cellu-
and this new evidence for nociceptor-specific calcium lar messengers, cAMP and Ca2. Because cAMP-depen-
channel variants are all reasons for enthusiasm about dent signaling is so prominent and essential to cells,
creating useful analgesics by targeting the N-type cal- multiple means of regulation have evolved to insure its
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